Back to Journals » OncoTargets and Therapy » Volume 7

Outcomes analysis of an alternative formulation of PEGylated liposomal doxorubicin in recurrent epithelial ovarian carcinoma during the drug shortage era

Total article views   HTML views PDF downloads Totals
9,621 Dovepress* 8,685+ 1,408 10,093
PubMed Central* 936 365 1,301
Totals 9,621 1,773 11,394
*Since 8 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar